EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 28-Jun-2025 05:10 ET (28-Jun-2025 09:10 GMT/UTC)

26-Jun-2025

NRG Oncology appoints new leaders to patient advocate committee and head and neck cancer committee

NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced that Tambre Leighn was appointed Committee Chair of the NRG Patient Advocate Committee (PAC) and Dr. Chris Holsinger was appointed Surgical Vice Chair of the NRG Head and Neck Cancer (HNC) Committee.

26-Jun-2025

ASTRO updates guideline on radiation therapy for high-grade diffuse glioma, the most common primary brain tumor in adults

American Society for Radiation Oncology
Peer-Reviewed Publication

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) focuses on the use of radiation therapy to treat adult patients with World Health Organization (WHO) grade 4 diffuse gliomas, a category that includes some of the most common and most aggressive primary brain tumors. The guideline, which replaces ASTRO’s 2016 guideline for glioblastoma, is published in Practical Radiation Oncology.

Journal: Practical Radiation Oncology

26-Jun-2025

Researchers decypher structure of a human protease implicated in various diseases

Universitat Autonoma de Barcelona
Peer-Reviewed Publication

A research led by the IBB-UAB has managed to decypher the structure of the human protease SENP5, implicated in neurodegenerative disorders, cardiovascular diseases and the development of cancer. The research, published in Nature Communications, paves the way for therapeutic opportunities with minimal side effects.

Journal: Nature Communications

26-Jun-2025

New gene therapy delivery device could let hospitals create personalized nanomedicines on-demand

Frontiers
Peer-Reviewed Publication

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine, as published in Frontiers in Science, could revolutionize how hospitals treat rare diseases, even in low-resource settings.

Journal: Frontiers in Science
Funder: Netherlands Science Agenda, Netherlands Organization for Scientific Research

26-Jun-2025

Saliva analysis could reveal the risk of developing cancer, heart disease or Parkinson’s

University of the Basque Country
Peer-Reviewed Publication

A research team led by the University of the Basque Country (Euskal Herriko Unibertsitatea, EHU) has identified hundreds of molecular markers in saliva that could reveal the risk of a person developing major diseases such as cancer, cardiovascular diseases, diabetes and neurodegenerative diseases. Their results lay the foundation for the development of a powerful, non-invasive tool for early diagnosis and precision medicine

Journal: npj Genomic Medicine

26-Jun-2025

Many older women may have undetected brain tumors

University of Gothenburg
Peer-Reviewed Publication

Tumors of the meninges are more common in older women than previously known. In a study from the University of Gothenburg, 2.7 percent of 70-year-old women in Sweden had such tumors. The researchers emphasize that such findings should be treated with diligence and careful consideration.

Journal: Acta Neurochirurgica

25-Jun-2025

In sub-Saharan Africa, 1 in 6 cancer medications found to be defective

University of Notre Dame
Peer-Reviewed Publication

Serious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.

Journal: The Lancet Global Health
Funder: NIH/National Cancer Institute

25-Jun-2025

Sylvester Cancer Tip Sheet - June 2025

University of Miami Miller School of Medicine
Reports and Proceedings

25-Jun-2025

Huntsman Cancer Institute Discovery Innovations Summer 2025

Huntsman Cancer Institute
Reports and Proceedings

Huntsman Cancer Institute’s latest breakthroughs—including a powerful drug combination for preventing melanoma brain metastasis, personalized exercise for recovery, and a groundbreaking stem cell transplant—are reshaping cancer care and research.

25-Jun-2025

Landmark study uncovers role of tumor microenvironment in nasopharyngeal carcinoma progression which supports personalized treatment

SingHealth
Peer-Reviewed Publication

Molecular profiling of over 1,000 nasopharyngeal cancer (NPC) patients’ tumours reveals distinct differences in tumour microenvironment of locoregionally advanced NPC, supporting the use of personalised treatment

Current treatment does not account for these biological differences, resulting in suboptimal outcomes

The study is the result of a 7-year-effort by the National Cancer Centre Singapore (NCCS), and validates ongoing clinical trials aimed at improving standards of care

Journal: Cell Reports Medicine